Related Experiment Video
Updated: Aug 16, 2026
10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
Medical management of obesity
1Medical Department, Hospital Barmherzige Brüder, Romanstrasse 93, 80639, Munich, Germany. Prof.Wechsler@barmherzige-muenchen.de
Langenbeck'S Archives of Surgery
|June 27, 2003
Summary
Obesity management requires an interdisciplinary approach. Effective weight loss involves very low-calorie diets, followed by fat-reduced, carbohydrate-rich diets, with medication and surgery as adjuncts for specific cases.
Area of Science:
- Obesity Medicine
- Metabolic Disease Research
Background:
- Obesity is a growing global health concern, defined as a chronic disease by the World Health Organization.
- It is linked to increased rates of illness and mortality.
- Current treatment success rates are often suboptimal.
Purpose of the Study:
- To outline an interdisciplinary and multimodal approach for treating overweight and obesity.
- To identify effective dietary strategies for significant body fat reduction.
- To clarify the role of pharmacotherapy and surgical interventions in obesity management.
Main Methods:
- Review of current obesity treatment modalities.
- Emphasis on dietary interventions, including very low-calorie diets (VLCDs) and subsequent macronutrient adjustments.
- Integration of pharmacotherapy and surgical options within comprehensive weight management programs.
Main Results:
- Very low-calorie diets followed by fat-reduced, carbohydrate-rich diets yield the best results for body weight and fat loss.
- Weight-loss medications are most effective when integrated into a program of diet and physical activity.
- Surgical intervention is reserved for individuals unresponsive to conservative treatments.
Conclusions:
- Structured, guideline-oriented, and quality-controlled programs are essential for effective obesity treatment.
- A multidisciplinary strategy is crucial for long-term patient success.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...